On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a ...

Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...

La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...

Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...